IL-6 in Low Back Pain

IL-6 is a inflammatory marker reported as elevated in Low Back Pain when patients are compared with the reference group of the cited comparison (chronic nonspecific LBP vs asymptomatic controls). The source does not tie this marker to a specific symptom cluster, so it is best read as a biological signal rather than a symptom predictor. The evidence summarised here comes from Injeyan et al. 2025 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedInflammatoryLOINC 26881-3

Summary

Direction in Low Back Pain↑ Elevated — higher than in the comparison group
CategoryInflammatory
Compared againstchronic nonspecific LBP vs asymptomatic controls
Test typeBlood test (serum / plasma / whole blood)
LOINC code26881-3
SourceInjeyan et al. 2025 — doi:10.1177/11772719251355038
Condition atlasLow Back Pain Biomarker Atlas

Other conditions where Interleukin-6 (IL-6) is reported

Atlas entryDirectionCompared against
Interleukin-6 in Atrial Fibrillation↕ inconsistentvs AF patients vs. implied healthy/reference
Interleukin-6 in Epilepsy↑ elevatedvs not explicitly named (comparison implied by disease state vs. normal/control)
Interleukin-6 (IL-6) in Gulf War Illness↑ elevatedvs HGV
Interleukin-6 (IL-6) in Long COVID↑ elevatedvs HC, R
Interleukin-6 (IL-6) in Lyme Disease↑ elevatedvs HC
IL-6 in Major Depressive Disorder↑ elevatedvs females with depression vs healthy female controls
Interleukin-6 (IL-6) in ME/CFS↕ inconsistentvs HC
Interleukin-6 in Migraine↑ elevatedvs headache-free controls
IL-6 in PACVS↑ elevatedvs HC
IL-6 in Rheumatoid Arthritis↑ elevatedvs RA vs healthy (established inflammatory pathway/drug target)

See the cross-condition hub: Interleukin-6 (IL-6) across conditions.

Related Inflammatory markers in Low Back Pain

Full list: Low Back Pain Biomarker Atlas.

Frequently asked questions

Is IL-6 high or low in Low Back Pain?

Elevated. Studies summarised in the OSMF atlas report higher IL-6 in Low Back Pain than in the reference group of the cited comparison (chronic nonspecific LBP vs asymptomatic controls). Source: Injeyan et al. 2025.

Which test measures IL-6?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 26881-3. Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal IL-6 result diagnostic of Low Back Pain?

No. No single biomarker is diagnostic of Low Back Pain. IL-6 findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is IL-6 specific to Low Back Pain?

No. The same marker is also reported in Atrial Fibrillation, Epilepsy, Gulf War Illness, Long COVID, Lyme Disease, ME/CFS, Major Depressive Disorder, Migraine, PACVS, Rheumatoid Arthritis in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). IL-6 in Low Back Pain: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/low-back-pain/il-6.html

Last reviewed: 2026-10-08 · Page generated from low-back-pain.json · Browse: Low Back Pain atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.